Divergent antibody-mediated population immunity to H5, H7 and H9 subtype potential pandemic influenza viruses
Stolle, L.; Bolton, J. S.; Steventon, R.; Gregory, R.; Klim, H.; Di Genova, C.; Haddock, L.; Bhatta, A.; Carnell, G.; Brady, C.; Da Costa, K.; Edmans, M.; Calliss, K.; Simmonds, P.; Hill, E. M.; Temperton, N.; Hill, S. C.; Jarvis, L.; McInally, C.; James, J.; Banyard, A. C.; Carroll, M.; Obolski, U.; Lambe, T.; Spencer, A.; Milicic, A.; Robb, N. C.; Thompson, C. P.
Show abstract
Influenza continues to cause significant mortality globally and possesses substantial pandemic potential. Assessing pandemic risk requires a clear understanding of existing population immunity. Leveraging a unique large-scale cohort of human sera, we evaluated total and neutralising antibody-mediated immunity to multiple haemagglutinin (HA) proteins, including those from subtypes with high pandemic potential. Our analysis reveals that population immunity is heterogeneous, with distinct age-dependent differences in responses to H5, H7, and H9 avian influenza subtypes. These shifts align with historical circulation patterns of seasonal H1N1 and H3N2 human viruses. Notably, H7 viruses are primarily neutralised through head domain epitopes, while H5 viruses are targeted mainly via stem epitopes, although in both instances some neutralisation occurred via receptor binding site-adjacent epitopes. Furthermore, H7 responses were dominated by non-glycan-targeted IgG2 antibodies, whereas H5 responses were primarily IgG1-mediated. These findings highlight varying levels of susceptibility to influenza across the population, supporting vaccination approaches informed by exposure history.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Neutralization of ancestral SARS-CoV-2 and variants Alpha, Beta, Gamma, Delta, Zeta and Omicron by mRNA vaccination and infection-derived immunity through homologous and heterologous variants 96%
- Human monoclonal antibodies that target clade 2.3.4.4b H5N1 hemagglutinin 95%
- Single-dose avian influenza A(H5N1) Clade 2.3.4.4b hemagglutinin-Matrix-M nanoparticle vaccine induces neutralizing responses in nonhuman primates 95%
Similar papers in this journal
- Targets of influenza Human T cell response are mostly conserved in H5N1 96%
- Low levels of H5N1 HA and NA antibodies in the human population are boosted by seasonal A/H1N1 infection but not by A/H3N2 infection or influenza vaccination 96%
- Population immunity to clade 2.3.4.4b H5N1 is dominated by anti-neuraminidase antibodies 96%
Similar papers in this journal
- Transmission event of SARS-CoV-2 Delta variant reveals multiple vaccine breakthrough infections 91%
- Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection 91%
- Human serum from SARS-CoV-2 vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant in comparison to the original Wuhan strain and the Beta and Delta variants 90%
Similar papers in this journal
Similar papers in this journal
- Poor neutralizing antibody responses against SARS-CoV-2 Omicron BQ.1.1 and XBB in Norway in October 2022 96%
- A rapid and flexible microneutralization assay for serological assessment of influenza viruses 94%
- Improved resolution of influenza vaccination responses with high-throughput live virus microneutralisation 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.